Search by Job Title

STX Sales Manager, SoutheastMaxCyte

THIS JOB HAS EXPIRED

Job Classification: Exempt
Status: Full-Time
Reports To: Vice President of Global Sales
Territory: AL, DE, FL, GA, KY, MD, MI, MS, NJ, NC, PA, SC, TN, VA, and WV
JOB SUMMARY:
This high-performance individual will manage current business and identify new opportunities
within existing accounts, as well as identify, pursue and close new opportunities within his/her
territory. Responsibilities include direct sales of the company?s transfection technology products
and/or services within a geographic territory of pharmaceutical, biotechnology, academic and
government accounts. (S)He must develop and maintain strategic account plans, report on
competitor activities, participate as part of global account team(s), and provide accurate forecasts
of sales activity. (S)He must become technically knowledgeable and able to deliver technical
seminar presentations on all MaxCyte products.
JOB DUTIES:
? Meet or exceed established sales targets for the territory
? Maintain strong relationships with existing customers
? Identify and develop in-roads into new accounts and sell to new accounts
? Develop and follow a territory management plan to maximize sales growth in the territory
? Follow up on all sales leads in a timely manner
? Provide accurate sales forecasts on a weekly basis
? Enter contact information and sales opportunity updates into CRM on a daily basis
? Conduct appropriate account research to understand the primary lines of business and financial
situation of every account and identify key decision makers within each account
? Provide effective presentations on the value of MaxCyte technology
? Provide quotations on MaxCyte technology
? Organize and oversee demonstrations of MaxCyte technology, working closely with the
applications team to insure the value of MaxCyte technology is clearly communicated to the
customer
JOB QUALIFICATIONS:
? Minimum BS in life sciences
? Located in the New Jersey or greater Philadelphia area
? 5+ years direct sales experience in companies that develop, market and sell life science tools to
biotechnology, pharmaceutical and research markets is required
? Experience selling capital equipment ($100K+) to pharmaceutical and biotech accounts in NJ,
PA, DE, and MD. Capital equipment sales experience must be recent experience.
? Proven track record of success
? Strong customer network especially in the areas of protein production, immunology, cell
biology, high throughput screening and high content screening.CONFIDENTIAL
? Strong territory management skills and availability for >60% overnight travel.
? Well-developed qualification skills and a thorough understanding of the sales process
complimented with the ability to move opportunities through the sales process.
? Strong technical knowledge in protein production, immunology, and cell based assays
? Understanding of transfections techniques and technologies
? Proven track record of success in entrepreneurial organization; ?roll up sleeves? with minimal
supervision and in-house resources to deliver performance objectives
? Ability to sell at any level in the customer organizations, from bench scientist to CEO
ADDITIONAL JOB QUALIFICATIONS:
? Must be results oriented
? Ability to project a positive image of self and MaxCyte
? Possess a contagious enthusiasm
? Ability to build strong relationships quickly
? Strong communication skills, both written and verbal, with the ability to earn the customers?
trust
? Ability to respond positively to constructive criticism and translate coaching into positive
behavioral changes
ABOUT MAXCYTE:
MaxCyte is a leader in cell transfection, bringing to market its patented flow electroporation
technology. MaxCyte is focused in applying its significant capabilities in the discovery,
development, and manufacturing of virtually all classes of innovative therapeutics targeting a
broad range of chronic and acute diseases. MaxCyte's customers and partners utilize its
technologies in the development and commercialization of cell-based therapies in regenerative
medicine and active cell immunotherapies and in the discovery and development of protein drugs,
monoclonal antibodies, vaccines, and small molecule drugs. This clinical-grade cell loading
technology is fully developed and well validated and has received Master File designation with
the CBER Division of the U.S. FDA, has been cleared by NIH's RAC and Health Canada, and is
commercialized in Japan. Considerable energy is devoted to R&D on new applications. These
efforts have led to the expanded application of our technology in pharmaceutical and
biotherapeutic drug discovery pipelines. Our instrumentation is currently placed in most of the
major global pharmaceutical companies and is used for high throughput/high content screening
and preclinical protein production. MaxCyte's technology uniquely fulfills the needs for high
quality, fully scalable cell modification in both the clinical and R&D arenas.